Insider Transactions in Q1 2024 at Data Knights Acquisition Corp. (DKDCW)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 22
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
100
+0.0%
|
$0
$0.79 P/Share
|
|
Mar 06
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
16
+0.0%
|
$0
$0.84 P/Share
|
|
Mar 05
2024
|
Eric Casaburi Director |
BUY
Open market or private purchase
|
Direct |
2,000
+3.88%
|
$0
$0.74 P/Share
|
|
Feb 29
2024
|
Eric Casaburi Director |
BUY
Open market or private purchase
|
Direct |
575
+1.19%
|
$0
$0.72 P/Share
|
|
Feb 16
2024
|
Eric Casaburi Director |
BUY
Open market or private purchase
|
Direct |
2,000
+4.08%
|
$0
$0.77 P/Share
|
|
Feb 16
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
100
+0.0%
|
$0
$0.82 P/Share
|
|
Feb 08
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
2
+0.0%
|
$2
$1.19 P/Share
|
|
Feb 01
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
1,357
+0.05%
|
$1,357
$1.45 P/Share
|
|
Jan 30
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
400
+0.02%
|
$400
$1.14 P/Share
|
|
Jan 29
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
950
+0.04%
|
$950
$1.04 P/Share
|
|
Jan 26
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
5,386
+0.21%
|
$0
$0.56 P/Share
|
|
Jan 25
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
2,304
+0.09%
|
$0
$0.55 P/Share
|
|
Jan 24
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
740
+0.03%
|
$0
$0.55 P/Share
|
|
Jan 23
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
720
+0.03%
|
$0
$0.52 P/Share
|
|
Jan 22
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
5,035
+0.2%
|
$0
$0.49 P/Share
|
|
Jan 19
2024
|
Eric Casaburi Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+50.0%
|
-
|
|
Jan 19
2024
|
Thomas Kosasa Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+0.53%
|
-
|
|
Jan 19
2024
|
Aaron Green Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+6.52%
|
-
|
|
Jan 19
2024
|
Robert Lawrence Golden Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+49.83%
|
-
|
|
Jan 19
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+1.76%
|
-
|
|
Jan 19
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
60
+0.0%
|
$0
$0.48 P/Share
|
|
Jan 17
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
362
+0.01%
|
$0
$0.61 P/Share
|
|
Jan 16
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$0
$0.75 P/Share
|
|
Jan 12
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
20
+0.0%
|
$0
$0.81 P/Share
|
|
Jan 10
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
20
+0.0%
|
$0
$0.85 P/Share
|
|
Jan 09
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
100
+0.0%
|
$0
$0.86 P/Share
|
|
Jan 08
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
10
+0.0%
|
$0
$0.83 P/Share
|
|
Jan 04
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
180
+0.01%
|
$0
$0.84 P/Share
|
|
Jan 02
2024
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
20
+0.0%
|
$0
$0.82 P/Share
|